A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 26, Issue 8, 1999, Pages 1676-1680

  Kamel, Onsi W ^a   Holly, Elizabeth A ^b   Van De Rijn, Matthijs ^b   Lele, Chitra ^b   Sah, Alexander ^b  

^a ST JOHN'S HOSPITAL   (United States)

^b NONE

Author keywords

Epstein Barr virus; Immunosuppression; Lymphoma; Lymphoproliferative disorder; Rheumatoid arthritis

Indexed keywords

ANALGESIC AGENT; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; AGED; ARTICLE; CANCER GRADING; CASE CONTROL STUDY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VIRUS GENOME;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED;

EID: 0032811876     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Probl Surg 1988;25:367-472.
2. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-81.
3. Biemer JJ. Malignant lymphomas associated with immunodeficiency states. Ann Clin Lab Sci 1990;20:175-91.
4. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;108:744-53.
5. Kersey JH, Shapiro RS, Filipovich AH. Relationship of immunodeficiency to lymphoid malignancy. Pediatr Infect Dis J 1988;7:S10.
6. Staal SP, Ambinder R, Beschorner WE, Hayward GS, Mann R. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am J Clin Pathol 1989;91:1-5.
7. Ellman MH, Hurwitz H, Thomas C, et al. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991;18:1741-3.
8. Shiroky JB, Frost A, Skelton JD, et al. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 1991;18:1172-5.
9. Zijlmans JM, van Rijthoven AW, Kluin PM, et al. Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine [letter]. New Engl J Med 1992;326:1363.
10. Kingsmore SF, Hall BD, Allen NB, et al. Association of methotrexate, rheumatoid arthritis and lymphoma. Report of 2 cases and literature review. J Rheumatol 1992;19:1462-5.
11. Kamel OW, van de Rijn M, Weiss LM, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. New Engl J Med 1993;328:1317-21.
12. Morris CR, Morris AJ. Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate [letter]. J Rheumatol 1993;20:2172-3.
13. Cobeta-Garcia JC, Ruiz-Jimeno MT, Fontova-Garrofe R. Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate [letter]. J Rheumatol 1993;20:200-2.
14. Taillan B, Garner G, Castanet J, et al. Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate. Clin Rheumatol 1993;12:93-4.
15. Shiroky JB, Newkirk MM. Reversible lymphomas [letter]. N Engl J Med 1993;329:1658.
16. Kamel OW, van de Rijn M, LeBrun DP, et al. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994;25:638-43.
17. Zimmer-Galler I, Lie JT. Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate. Mayo Clin Proc 1994;69:259-62.
18. Ferraccioli GF, Casatta L, Bartoli E, et al. Epstein-Barr virus associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A [letter]. Arthritis Rheum 1995;6:867-8.
19. Thomason RW, Craig FE, Banks PM, et al. Epstein-Barr virus and lymphoproliferation in methotrexate treated rheumatoid arthritis. Mod Pathol 1996;9:261-6.
20. van de Rijn M, Cleary ML, Variakojis D, et al. Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:638-42.
21. Salloum E, Cooper DL, Gowe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996;14:1943-9.
22. Kamel OW, Weiss LM, van de Rijn M, et al. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term, low-dose methotrexate therapy. Am J Surg Pathol 1996;20:1279-87.
23. Kamel OW. Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin Diag Pathol 1997;14:27-34.
24. Holly EA, Lele C. Non-Hodgkin's lymphoma in HIV+ and HIV-homosexual men in the San Francisco Bay area: allergies, prior medication use and sexual practices. J Acquir Imm Def Syndr Hum Retrovir 1997;15:211-22.
25. Holly EA, Lele C, Bracci P. Non-Hodgkin's lymphoma in homosexual men in the San Francisco Bay area: occupational, chemical and environmental exposures. J Acquir Imm Def Syndr Hum Retrovir 1997;15:222-31.
26. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas, summary and description of a Working Formulation for clinical usage. Cancer 1982;49:2112-35.
27. Chan JK, Banks PM, Cleary ML, et al. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathol 1994;25:517-36.
28. Bindl JM, Warnke RA. Advantages to detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in coplin jars. Am J Clin Pathol 1986;85:490-3.
29. Yao M, Cheng AL, Su IJ, et al. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Br J Haematol 1994;87:535-43.
30. Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer 1993;72:909-16.
31. Cleary ML, Nalesnik MA, Shearer WT, Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988;72:349-52.
32. Hakulinen T, Isomaki H, Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985;78 Suppl 1A:29-32.
33. Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 1985;78 Suppl 1A:15-21.
34. Symmons DPM. Neoplasms of the immune system in rheumatoid arthritis. Am J Med 1985;78 Suppl 1A:22-8.
35. Castor CW, Bull FE. Review of United States data on neoplasms in rheumatoid arthritis. Am J Med 1985;78 Suppl 1A:33-8.
36. Kinlen LJ. Malignancy in autoimmune diseases. J Autoimmun 1992;5 Suppl A:363-71.
37. Cash JM, Klippel JH. Second-line therapy for rheumatoid arthritis. N Engl J Med 1994;330:1368-75.